Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bullock

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Medical Quarterly Review|November 8, 2018
Case of EmpyemaJohn Bullock
The Medical Quarterly Review|November 8, 2018
On the Use of Colchicum in ErysipelasJohn Bullock
Journal of Pharmaceutical Sciences|January 4, 2012
A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogsKevin Quinn, Rampurna Prasad Gullapalli, Elaine Merisko-Liversidge, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Medical Quarterly Review|November 8, 2018
Case of EmpyemaJohn Bullock
The Medical Quarterly Review|November 8, 2018
On the Use of Colchicum in ErysipelasJohn Bullock
Journal of Pharmaceutical Sciences|January 4, 2012
A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogsKevin Quinn, Rampurna Prasad Gullapalli, Elaine Merisko-Liversidge, et al.
Pageof 1